IPO Watch

City Therapeutics Sets Terms for $175 Million IPO

Cambridge, Massachusetts-based clinical biotech firm City Therapeutics has set terms for its upcoming initial public offering on the NASDAQ under…

- Advertisement -
Ad image

The IPO  Buzz: ADARx Pharmaceuticals Upsizes IPO & Prices it at $17 – High End

San Diego-based biotechnology firm ADARx Pharmaceuticals, Inc. has officially priced its upsized initial public offering (IPO) at $17.00 per share—the…

Accelevation (ACCV Proposed) Sets Terms for $660 Million IPO

As artificial intelligence models expand and hyper-scaler data centers push electrical grids to their limit, one critical industry has emerged…